We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Growing Long-Term Use of LVADs

By HospiMedica staff writers
Posted on 16 Nov 2004
The success of long-term implantable left ventricular-assist devices (LVADs) has led to their increased use in patients previously thought to be unsuitable for mechanical support.

A study published in the September-October 2004 issue of the Journal of Cardiac Surgery documents this shift in the profile of patients in need of artificial hearts to a higher risk group. More...
Researchers looked at the clinical records of 131 consecutive recipients of a LVAD as a bridge-to-transplantation, and found that despite the high-risk status of the patients, the overall mortality rate remained low at 50%. These results could have implications for the funding of artificial heart programs whereby more patients in the high-risk category would be candidates for mechanical assistance.

"The results continue to emphasize that patient selection is the predominant criteria for success in artificial heart programs, but that high-risk patients can be helped in experienced centers,” noted author Dr. Vivec Rao, surgical director of heart transplantation and mechanical circulatory assistance at the Toronto General Hospital.




Related Links:
Toronto General Hospital

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Autus valve can be implanted at about 13 mm in young children and expanded up to 22 mm as they grow using a balloon catheter. (Photo courtesy of Edwards Lifesciences)

New FDA-Approved Pediatric Pulmonary Valve Can Expand as Children Grow

Congenital pulmonary valve disease affects the valve that directs blood from the heart to the lungs. Even after repair, some children develop valve leakage that can strain and enlarge the right side of the heart.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.